Covered recipient · General Payments record
THOMAS JEROME HERR
Allopathic & Osteopathic Physicians Pediatrics
General Payments · PY2018–2021
$660.93
- Reported across 38 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2021 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $139.85 | 9 |
By paying entity
PY2021 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | $61.25 | 4 |
| Merck Sharp & Dohme Corporation | $37.04 | 2 |
| Adlon Therapeutics L.P. | $16.72 | 1 |
| Genentech USA, Inc. | $13.69 | 1 |
| PFIZER INC. | $11.15 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2021 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Adlon Therapeutics L.P. | $16.72 | 09/14/2021 | Food and Beverage | Undisputed | 01/23/2026 | 844832751 | CMS |
| Genentech USA, Inc. | $13.69 | 11/09/2021 | Food and Beverage | Undisputed | 01/23/2026 | 835984713 | CMS |
| Merck Sharp & Dohme Corporation | $19.38 | 04/14/2021 | Food and Beverage | Undisputed | 01/23/2026 | 848456381 | CMS |
| Merck Sharp & Dohme Corporation | $17.66 | 07/27/2021 | Food and Beverage | Undisputed | 01/23/2026 | 848619343 | CMS |
| PFIZER INC. | $11.15 | 08/17/2021 | Food and Beverage | Undisputed | 01/23/2026 | 832788279 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $16.08 | 04/21/2021 | Food and Beverage | Undisputed | 01/23/2026 | 819972803 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $13.38 | 08/31/2021 | Food and Beverage | Undisputed | 01/23/2026 | 819972805 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $14.91 | 11/03/2021 | Food and Beverage | Undisputed | 01/23/2026 | 819972809 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $16.88 | 12/08/2021 | Food and Beverage | Undisputed | 01/23/2026 | 819972813 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021
- Generated from
- OP_DTL_GNRL_PGYR2021_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.